PD-1 Antibody SHR-1210 in Patients With Relapsed or Refractory Classic Hodgkin's Lymphoma

Clinical trial NCT03155425 · COMPLETED

Trial details

NCT number: NCT03155425
Sponsor: Jiangsu HengRui Medicine Co., Ltd.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Hodgkin Lymphoma, Adult

Start date: 2017-06-09
Primary completion: 2020-08-31
Enrollment: 75

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.